About 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one
4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one (PubChem CID 95313764) has the molecular formula C18H20N4O3
and a molecular weight of 340.38 g/mol. Its IUPAC name is 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one.
Analyze 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one?
The IUPAC name of 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one (CID 95313764) is 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one.
What is the SMILES notation for 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one?
The canonical SMILES for 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one is O=C(CN1C(=O)COc2ccccc21)N1CCC[C@H](n2ccnc2)C1.
What is the InChIKey of 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one?
The InChIKey is WAYQNNSXMLRHEP-AWEZNQCLSA-N. The full InChI is InChI=1S/C18H20N4O3/c23-17(20-8-3-4-14(10-20)21-9-7-19-13-21)11-22-15-5-1-2-6-16(15)25-12-18(22)24/h1-2,5-7,9,13-14H,3-4,8,10-12H2/t14-/m0/s1.
What are the key properties of 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one?
4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one has a molecular weight of 340.38 g/mol, XLogP of 1.47, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-[(3S)-3-imidazol-1-ylpiperidin-1-yl]-2-oxoethyl]-1,4-benzoxazin-3-one is sourced from PubChem (CID 95313764), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).